Savant Capital LLC Grows Stake in Globe Life Inc. (NYSE:GL)

Savant Capital LLC boosted its position in shares of Globe Life Inc. (NYSE:GL) by 0.3% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 56,045 shares of the company’s stock after purchasing an additional 149 shares during the quarter. Savant Capital LLC owned about 0.07% of Globe Life worth $6,250,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of the company. Canvas Wealth Advisors LLC increased its holdings in Globe Life by 7.1% during the 4th quarter. Canvas Wealth Advisors LLC now owns 9,596 shares of the company’s stock worth $1,070,000 after purchasing an additional 638 shares during the period. Fairvoy Private Wealth LLC purchased a new position in Globe Life during the 4th quarter worth $1,367,000. Sumitomo Mitsui Trust Group Inc. increased its holdings in Globe Life by 719.5% during the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 24,225 shares of the company’s stock worth $2,702,000 after purchasing an additional 21,269 shares during the period. Mirae Asset Global Investments Co. Ltd. increased its holdings in Globe Life by 39.5% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 8,988 shares of the company’s stock worth $984,000 after purchasing an additional 2,547 shares during the period. Finally, Stratos Wealth Advisors LLC purchased a new position in Globe Life during the 4th quarter worth $208,000. 81.61% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research analysts have commented on the company. Truist Financial raised their price objective on Globe Life from $90.00 to $105.00 and gave the stock a “hold” rating in a report on Friday, October 25th. BMO Capital Markets started coverage on Globe Life in a research report on Thursday, January 23rd. They set a “market perform” rating and a $114.00 target price on the stock. Morgan Stanley increased their target price on Globe Life from $110.00 to $120.00 and gave the company an “equal weight” rating in a research report on Thursday, October 24th. Evercore ISI raised Globe Life from an “in-line” rating to an “outperform” rating and increased their target price for the company from $132.00 to $143.00 in a research report on Wednesday, January 8th. Finally, Jefferies Financial Group increased their target price on Globe Life from $107.00 to $114.00 and gave the company a “hold” rating in a research report on Tuesday, December 10th. Five equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Globe Life has a consensus rating of “Moderate Buy” and an average target price of $131.80.

Insiders Place Their Bets

In other Globe Life news, CEO Frank M. Svoboda sold 13,448 shares of Globe Life stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $112.56, for a total transaction of $1,513,706.88. Following the completion of the sale, the chief executive officer now owns 18,948 shares of the company’s stock, valued at approximately $2,132,786.88. The trade was a 41.51 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Mark A. Blinn sold 3,000 shares of Globe Life stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $113.23, for a total value of $339,690.00. Following the sale, the director now directly owns 5,122 shares of the company’s stock, valued at approximately $579,964.06. This represents a 36.94 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 39,788 shares of company stock valued at $4,429,779. 1.51% of the stock is owned by company insiders.

Globe Life Stock Down 1.0 %

Globe Life stock opened at $122.29 on Tuesday. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.05 and a quick ratio of 0.05. The stock has a market capitalization of $10.26 billion, a price-to-earnings ratio of 10.23 and a beta of 0.81. Globe Life Inc. has a 1-year low of $38.95 and a 1-year high of $132.00. The business has a fifty day moving average price of $113.44 and a 200-day moving average price of $107.35.

Globe Life (NYSE:GL) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $3.14 earnings per share for the quarter, topping analysts’ consensus estimates of $3.12 by $0.02. Globe Life had a return on equity of 22.32% and a net margin of 18.53%. Equities research analysts forecast that Globe Life Inc. will post 13.57 EPS for the current fiscal year.

Globe Life Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Monday, January 6th were given a dividend of $0.24 per share. The ex-dividend date of this dividend was Monday, January 6th. This represents a $0.96 dividend on an annualized basis and a yield of 0.79%. Globe Life’s dividend payout ratio is currently 8.03%.

Globe Life Company Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.